Integrating New Options Into Guideline-Directed Management of Heart Failure with Reduced Ejection Fraction
Premiere Date: Thursday, February 23, 2017This activity offers CE credit for:
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Friday, February 23, 2018
Note: Credit Is No Longer Available
 | Ty J. Gluckman, MD, FACC, FAHA (Moderator) Medical Director Clinical Transformation Providence Heart and Vascular Institute Portland, OR Adjunct Member The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Baltimore, MD |
 | Joseph O. Lambert, MD Medical Director, Innovative Infusions Sub Investigator, North Hills Medical Research, Inc. President, North Hills Family Medicine Quality Committee Member, Catalyst Health Network North Richland Hills, TX |
 | Bradley M. Leonard, MD, MBA, FACC Managing Partner Advanced Heart Care Chief, Division of Cardiovascular Services Wise Health System Dallas, TX |
 | Tony Willoughby, PharmD President Thrive Pharmacy Solutions Plano, TX |
Heart failure (HF) is a chronic condition that requires long-term commitment on the part of the patient in adhering to an often-complex therapeutic and monitoring regimen, including lifestyle modifications and pharmacotherapy, and on the part of the clinician in maintaining knowledge to prescribe the most advantageous interventions. Although guidelines are widely available for the treatment of HF, gaps exist between these guidelines and actual care. Additionally, newly available remote monitoring systems for patients with HF allow the clinician to intervene before increasing decompensation occurs, thereby decreasing hospital admissions.1
This CME Outfitters Live and On Demand will feature expert faculty presenting the rationale and evidence for clinicians to incorporate guidelines for the most up-to-date treatment and monitoring strategies for their patients with HF to improve quality of life and decrease hospital readmissions.
Reference:
1. Adamson PB, Abraham WT, Bourge RC, et al. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction. Circ Heart Fail.2014;7(6):935-944.
At the end of this CE activity, participants should be able to:
- Increase the rate of compliance with prescribing of guideline-directed therapy in patients with heart failure with reduced ejection fraction.
- Incorporate evidence from the latest clinical trials, including mechanism of action of new drugs, into decision-making regarding the treatment of chronic heart failure.
- Reduce the rate of 30- and 90-day hospital readmission for patients with heart failure.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Describe ways to increase the rate of compliance with prescribing of guideline-directed therapy in patients with heart failure with reduced ejection fraction.
- Identify evidence from the latest clinical trials, including mechanism of action of new drugs, that can be incorporated into decision-making regarding the treatment of chronic heart failure.
- Explain how to reduce the rate of 30- and 90- day hospital readmission for patients with heart failure.
This activity is supported by educational funding provided by Amgen, Novartis Pharmaceuticals Corporation and St. Jude Medical, Inc.
Cardiologists, internists, primary care physicians, physician assistants, nurse practitioners, pharmacists, and other healthcare professionals with an interest in heart failure.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours
Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.5 contact hours of pharmacotherapeutic contact hours.
Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 CreditTM through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)TM from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number:
0376-0000-17-002-L01-P (live)
0376-0000-17-002-H01-P (enduring)
Type: knowledge-based
Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.
Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST21196 (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Gluckman has no disclosures to report.
Dr. Lambert has no disclosures to report.
Dr. Leonard has no disclosures to report.
Dr. Willoughby has no disclosures to report.
Jeffrey Helfand, DO, MS (peer reviewer) has no disclosures to report.
Kimberley Murray, RN, MPH (peer reviewer) has no disclosures to report.
Kashemi D. Rorie, PhD (planning committee) has no disclosures to report.
Jan Perez, CHCP (planning committee) has no disclosures to report.
Sharon Tordoff, CHCP (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: Nothing to Disclose
Unlabeled Use Disclosure
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
TV-088-022317-90
